OTCMKTS:SARTF

Sartorius Aktiengesellschaft Stock Forecast, Price & News

$444.50
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$444.50
Now: $444.50
$444.50
50-Day Range
$411.00
MA: $458.70
$550.00
52-Week Range
$217.05
Now: $444.50
$550.00
VolumeN/A
Average Volume100 shs
Market Capitalization$15.21 billion
P/E Ratio159.32
Dividend YieldN/A
Beta0.58
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Sartorius Aktiengesellschaft logo

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SARTF
Previous SymbolNASDAQ:SARTF
CUSIPN/A
CIKN/A
Phone49-55-130-80
Employees10,637
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.61 billion
Cash Flow$11.95 per share
Book Value$38.55 per share

Profitability

Net Income$262.72 million

Miscellaneous

Market Cap$15.21 billion
Next Earnings Date4/20/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.84 out of 5 stars

Medical Sector

1159th out of 2,010 stocks

Dental Equipment & Supplies Industry

6th out of 8 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$444.50
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SARTF News and Ratings via Email

Sign-up to receive the latest news and ratings for SARTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Frequently Asked Questions

Is Sartorius Aktiengesellschaft a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sartorius Aktiengesellschaft in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Sartorius Aktiengesellschaft stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SARTF, but not buy additional shares or sell existing shares.
View analyst ratings for Sartorius Aktiengesellschaft
or view top-rated stocks.

What stocks does MarketBeat like better than Sartorius Aktiengesellschaft?

Wall Street analysts have given Sartorius Aktiengesellschaft a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sartorius Aktiengesellschaft wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sartorius Aktiengesellschaft's next earnings date?

Sartorius Aktiengesellschaft is scheduled to release its next quarterly earnings announcement on Tuesday, April 20th 2021.
View our earnings forecast for Sartorius Aktiengesellschaft
.

How has Sartorius Aktiengesellschaft's stock been impacted by COVID-19?

Sartorius Aktiengesellschaft's stock was trading at $224.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SARTF shares have increased by 98.4% and is now trading at $444.50.
View which stocks have been most impacted by COVID-19
.

Who are Sartorius Aktiengesellschaft's key executives?

Sartorius Aktiengesellschaft's management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 56)
  • Mr. Rainer Lehmann, CFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 46)
  • Dr. Rene Faber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 46)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 52)
  • Mr. John Gerard Mackay, Head of Lab Products & Services Division and Member of Exec. Board (Age 59)
  • Mr. Manfred Werner, Sr. VP of Admin. Organization & Auditing
  • Ms. Mei Wang, Head of Production - China
  • Ms. Patricia Spannagel, Head of Quality Assurance - Mechatronics Division Goettingen
  • Mr. Rashid Maqbool, Head of Production & Certification Department - Denver USA
  • Mr. Manohar Kuppusami, Head of Production Department - India

Who are some of Sartorius Aktiengesellschaft's key competitors?

What is Sartorius Aktiengesellschaft's stock symbol?

Sartorius Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "SARTF."

How do I buy shares of Sartorius Aktiengesellschaft?

Shares of SARTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sartorius Aktiengesellschaft's stock price today?

One share of SARTF stock can currently be purchased for approximately $444.50.

How much money does Sartorius Aktiengesellschaft make?

Sartorius Aktiengesellschaft has a market capitalization of $15.21 billion and generates $1.61 billion in revenue each year. The company earns $262.72 million in net income (profit) each year or $3.19 on an earnings per share basis.

How many employees does Sartorius Aktiengesellschaft have?

Sartorius Aktiengesellschaft employs 10,637 workers across the globe.

What is Sartorius Aktiengesellschaft's official website?

The official website for Sartorius Aktiengesellschaft is www.sartorius.com.

Where are Sartorius Aktiengesellschaft's headquarters?

Sartorius Aktiengesellschaft is headquartered at OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079.

How can I contact Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft's mailing address is OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079. The company can be reached via phone at 49-55-130-80 or via email at [email protected]


This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.